Growth Metrics

Eli Lilly (LLY) Change in Cash (2016 - 2026)

Eli Lilly filings provide 18 years of Change in Cash readings, the most recent being -$2.0 billion for Q1 2026.

  • On a quarterly basis, Change in Cash fell 1034.86% to -$2.0 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $2.2 billion, a 246.14% increase, with the full-year FY2025 number at $4.0 billion, up 790.87% from a year prior.
  • Change in Cash hit -$2.0 billion in Q1 2026 for Eli Lilly, up from -$2.5 billion in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $6.4 billion in Q3 2025 to a low of -$2.5 billion in Q4 2025.
  • Median Change in Cash over the past 5 years was -$101.4 million (2024), compared with a mean of $86.1 million.
  • Biggest five-year swings in Change in Cash: tumbled 5603.64% in 2023 and later skyrocketed 4312.65% in 2025.
  • Eli Lilly's Change in Cash stood at -$550.4 million in 2022, then surged by 179.61% to $438.2 million in 2023, then crashed by 123.14% to -$101.4 million in 2024, then tumbled by 2388.66% to -$2.5 billion in 2025, then rose by 21.3% to -$2.0 billion in 2026.
  • The last three reported values for Change in Cash were -$2.0 billion (Q1 2026), -$2.5 billion (Q4 2025), and $6.4 billion (Q3 2025) per Business Quant data.